These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3398430)

  • 1. [Comparison of the hemodynamics effects of D-sotalol and D,L-sotalol].
    Hoffmeister HM; Seipel L
    Klin Wochenschr; 1988 May; 66(10):451-4. PubMed ID: 3398430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the new class-III antiarrhythmic drug D-sotalol on contractile function of postischemic myocardium.
    Hoffmeister HM; Müller S; Seipel L
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):581-6. PubMed ID: 1711624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effects of cibenzoline on normal myocardium and after pretreatment with DL-sotalol.
    Beyer ME; Hoffmeister HM; Seipel L
    J Cardiovasc Pharmacol; 1992 May; 19(5):657-64. PubMed ID: 1381761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of the D- and L-isomers of sotalol on normal myocardium.
    Hoffmeister HM; Beyer M; Seipel L
    Cardiovasc Drugs Ther; 1991 Dec; 5(6):1027-33. PubMed ID: 1801889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inotropic and haemodynamic effects of d- and d,l-sotalol: comparison with other antiarrhythmics.
    Seipel L; Hoffmeister HM
    Eur Heart J; 1993 Nov; 14 Suppl H():36-40. PubMed ID: 7904937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of antiarrhythmic compounds: intrinsic effects and autonomic modulation.
    Hoffmeister HM; Beyer ME; Seipel L
    Am J Cardiol; 1997 Oct; 80(8A):24G-30G. PubMed ID: 9354409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative hemodynamic effects of amiodarone, sotalol, and d-sotalol.
    Twidale N; Roberts-Thomson P; McRitchie RJ
    Am Heart J; 1993 Jul; 126(1):122-9. PubMed ID: 8322653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial and circulatory effects of inosine.
    Hoffmeister HM; Betz R; Fiechtner H; Seipel L
    Cardiovasc Res; 1987 Jan; 21(1):65-71. PubMed ID: 3664538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental studies of the hemodynamics of disopyramide in comparison with quinidine].
    Hoffmeister HM; Hepp A; Seipel L
    Z Kardiol; 1988 Jan; 77(1):48-52. PubMed ID: 3363980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Modification of hemodynamics by intravenous administration of flecainide].
    Hoffmeister HM; Hepp A; Seipel L
    Z Kardiol; 1986 Mar; 75(3):176-81. PubMed ID: 3705689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic basis of the antiarrhythmic and hemodynamic effects of sotalol.
    Antonaccio MJ; Gomoll A
    Am J Cardiol; 1993 Aug; 72(4):27A-37A. PubMed ID: 8346723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term myocardial uptake of d- and l-sotalol in humans: relation to hemodynamic and electrophysiologic effects.
    Ritchie RH; Sallustio BC; Hii JT; Horowitz JD
    J Cardiovasc Pharmacol; 1998 Jun; 31(6):876-84. PubMed ID: 9641472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of the rise in extracellular potassium concentration during myocardial ischaemia by d.l-sotalol and d-sotalol.
    Hicks MN; Cobbe SM
    Cardiovasc Res; 1990 May; 24(5):404-10. PubMed ID: 2372795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the Na+ antagonist cibenzoline on left ventricular function of postischemic hearts.
    Hoffmeister HM; Beyer ME; Seipel L
    Cardiovasc Drugs Ther; 1995 Apr; 9(2):351-7. PubMed ID: 7662603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and inotropic effects of endothelin-1 in vivo.
    Beyer ME; Nerz S; Krämer BK; Hoffmeister HM
    Basic Res Cardiol; 1994; 89(1):39-49. PubMed ID: 8010934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive and negative inotropic effects of DL-sotalol and D-sotalol in failing and nonfailing human myocardium under physiological experimental conditions.
    Holubarsch C; Schneider R; Pieske B; Ruf T; Hasenfuss G; Fraedrich G; Posival H; Just H
    Circulation; 1995 Nov; 92(10):2904-10. PubMed ID: 7586258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic profiles of d-sotalol and d,l-sotalol.
    Funck-Brentano C
    Eur Heart J; 1993 Nov; 14 Suppl H():30-5. PubMed ID: 7904936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative beta-blocking activities and electrophysiologic actions of racemic sotalol and its optical isomers in anesthetized dogs.
    Gomoll AW; Bartek MJ
    Eur J Pharmacol; 1986 Dec; 132(2-3):123-35. PubMed ID: 2880732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparability of the electrophysiologic responses and plasma and myocardial tissue concentrations of sotalol and its d stereoisomer in the dog.
    Gomoll AW; Lekich RF; Bartek MJ; Comereski CR; Antonaccio MJ
    J Cardiovasc Pharmacol; 1990 Aug; 16(2):204-11. PubMed ID: 1697375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in-vivo cardiovascular effects of a putative class III anti-arrhythmic drug, AM 92016.
    Hagerty MJ; Wainwright CL; Kane KA
    J Pharm Pharmacol; 1996 Apr; 48(4):417-21. PubMed ID: 8794994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.